Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.41 |
| ▸ | FABP3 | P05413 | 3/20 | 0.35 |
| ▸ | FABP4 | P15090 | 3/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5149004 | 0.90 | PTGS2 (0.53) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL5149019 | 0.90 | PTGS2 (0.53) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL5149013 | 0.90 | PTGS2 (0.53) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL5151756 | 0.80 | PTGS2 (0.56) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL5151744 | 0.80 | PTGS2 (0.56) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL5151722 | 0.80 | PTGS2 (0.56) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL5148842 | 0.76 | PTGS2 (0.61) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL5155149 | 0.74 | PTGS2 (0.62) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL5150878 | 0.74 | PTGS2 (0.62) | PTGS2FABP3FABP4PTGS1 | |
| SCHEMBL3873490 | 0.73 | FABP3 (0.40) | PTGS2FABP3FABP4PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1539679-A4 | OXIME AND/OR HYDRAZONE CONTAINING NITROSATED AND/OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2007-07-04 | — | — | EP | claimed |
| EP-1539679-A2 | OXIME AND/OR HYDRAZONE CONTAINING NITROSATED AND/OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2005-06-15 | — | — | EP | claimed |
| WO-2004002420-A2 | OXIME AND/OR HYDRAZONE CONTAINING NITROSATED AND/OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2004-01-08 | — | — | WO | claimed |